BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32599245)

  • 1. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
    Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
    Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protein interaction map identifies existing drugs targeting SARS-CoV-2.
    Cava C; Bertoli G; Castiglioni I
    BMC Pharmacol Toxicol; 2020 Sep; 21(1):65. PubMed ID: 32883368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
    Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
    Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).
    Arora S; Singh P; Dohare R; Jha R; Ali Syed M
    Gene; 2020 Dec; 762():145057. PubMed ID: 32805314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis.
    Xie TA; Han MY; Su XR; Li HH; Chen JC; Guo XG
    J Cell Mol Med; 2020 Oct; 24(20):12225-12230. PubMed ID: 32924263
    [No Abstract]   [Full Text] [Related]  

  • 8. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation and evasion of type I interferon responses by SARS-CoV-2.
    Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
    Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19.
    Yuan J; Fan D; Xue Z; Qu J; Su J
    Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):13. PubMed ID: 33049061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
    Biterge Süt B
    Life Sci; 2020 Oct; 258():118170. PubMed ID: 32735883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug targets for COVID-19 therapeutics: Ongoing global efforts.
    Saxena A
    J Biosci; 2020; 45(1):. PubMed ID: 32661214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and SARS-CoV-2: points to consider to face this new pandemic.
    Prieto Pozo AA; Salvador Sagüez FLD
    Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A contemporary review on pathogenesis and immunity of COVID-19 infection.
    Mirzaei R; Karampoor S; Sholeh M; Moradi P; Ranjbar R; Ghasemi F
    Mol Biol Rep; 2020 Jul; 47(7):5365-5376. PubMed ID: 32601923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
    Fagone P; Ciurleo R; Lombardo SD; Iacobello C; Palermo CI; Shoenfeld Y; Bendtzen K; Bramanti P; Nicoletti F
    Autoimmun Rev; 2020 Jul; 19(7):102571. PubMed ID: 32376402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
    Zeng X; Song X; Ma T; Pan X; Zhou Y; Hou Y; Zhang Z; Li K; Karypis G; Cheng F
    J Proteome Res; 2020 Nov; 19(11):4624-4636. PubMed ID: 32654489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
    Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
    Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
    J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
    Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
    J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.